|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/08 | |
| C07D 401/04 | |||
| A61P 25/00 | |||
| A61P 25/02 | |||
| A61P 25/04 | |||
| A61P 25/18 | |||
| A61P 25/28 | |||
| A61P 25/30 | |||
| A61P 29/00 | |||
| A61P 43/00 | |||
| A61K 31/451 | |||
| A61K 31/4523 | |||
| A61P 25/14 |
| (11) | Number of the document | 3331869 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16750223.6 |
| Date of filing the European patent application | 2016-08-03 | |
| (97) | Date of publication of the European application | 2018-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2016/052386 |
| Date | 2016-08-03 |
| (87) | Number | WO 2017/021730 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201513742 | 2015-08-03 | GB |
| (72) |
BROWN, Giles Albert, GB
CONGREVE, Miles Stuart, GB
PICKWORTH, Mark, GB
TEHAN, Benjamin Gerald, GB
|
| (73) |
Heptares Therapeutics Limited,
Granta Park Great Abington, Cambridge CB21 6DG,
GB
|
| (54) | MUSCARINIC AGONISTS |
| MUSCARINIC AGONISTS |